Sandoz’s Claire D’Abreu-Hayling on leading with love - European Medical Journal

Sandoz’s Claire D’Abreu-Hayling on leading with love

EMJ GOLD

This week, Claire D’Abreu-Hayling, Chief Scientific Officer, Sandoz, joins us to share how leading with love rather than ruling with an iron fist is the best way to get results in the pharmaceutical industry.

In this episode, Claire discuss how she fell in love with science as a child, the leadership skills she has gained over the course of her career and the importance of valuing your people and being valued in return. 

A little more on EMJ GOLD’s guest…

Claire D’Abreu-Hayling is the Chief Scientific Officer at Sandoz, and with more than 30 years of experience in the pharmaceutical industry under her belt, she knows a thing or two about life sciences leadership – past and present. At the company Claire oversees the global product development network where she manages infrastructure strategy, pipeline execution and talent acquisition for both small molecules and biosimilars. Outside of work, Claire is a true champion of authenticity in the workplace. She is passionate about diversity, equity and inclusion and is particularly committed to mentoring Black and Asian women who are pursuing careers in STEM.  

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.